Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA009307-19
Application #
2085252
Study Section
Cancer Institutional Fellowship Review Committee (CT)
Project Start
1978-08-01
Project End
1998-06-30
Budget Start
1996-07-01
Budget End
1997-06-30
Support Year
19
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Duke University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Herold, Christina I; Gasparetto, Cristina; Arepally, Gowthami M (2011) Lenalidomide-Associated ITP. Case Rep Hematol 2011:638020
Dixon, Natalia E; Crissman, Blythe G; Smith, P Brian et al. (2010) Prevalence of iron deficiency in children with Down syndrome. J Pediatr 157:967-971.e1
Kuderer, Nicole M; Peppercorn, Jeffrey (2009) CYP2D6 testing in breast cancer: ready for prime time? Oncology (Williston Park) 23:1223-32
Lyman, Gary H; Kuderer, Nicole M; Freedland, Stephen J (2009) Does treatment intensity matter in superficial bladder cancer? Consensus, clinical practice, and confounding. J Natl Cancer Inst 101:543-5
Kuderer, Nicole M; Ortel, Thomas L; Francis, Charles W (2009) Impact of venous thromboembolism and anticoagulation on cancer and cancer survival. J Clin Oncol 27:4902-11
Kuderer, Nicole M; Lyman, Gary H (2009) Gene expression profile assays as predictors of distant recurrence-free survival in early-stage breast cancer. Cancer Invest 27:885-90
Herold, Christina I; Blackwell, Kimberly L (2008) The impact of adjuvant endocrine therapy on reducing the risk of distant metastases in hormone-responsive breast cancer. Breast 17 Suppl 1:S15-24
Dixon, Natalia; Kishnani, Priya S; Zimmerman, Sherri (2006) Clinical manifestations of hematologic and oncologic disorders in patients with Down syndrome. Am J Med Genet C Semin Med Genet 142C:149-57
Fang, Yanan; Linardic, Corinne M; Richardson, D Ashley et al. (2003) Characterization of the cytotoxic activities of novel analogues of the antitumor agent, lavendamycin. Mol Cancer Ther 2:517-26
Edinger, Aimee L; Linardic, Corinne M; Chiang, Gary G et al. (2003) Differential effects of rapamycin on mammalian target of rapamycin signaling functions in mammalian cells. Cancer Res 63:8451-60

Showing the most recent 10 out of 37 publications